Baclofen for psychomotor agitation

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Mar 2016: Trial registered, NCT02723383
  2. 27 Jun 2016: Trial started, NCT02723383

The trials

NCT02723383: Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU

State
Completed
Phase
Phase 3
People
314 taking part
Started
27 Jun 2016
Primary completion
14 Aug 2019
Arms
BACLOFEN
Results
None posted
  1. 30 Mar 2016: Trial registered
  2. 27 Jun 2016: Trial started
  3. 14 Aug 2019: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Baclofen 30mg, Baclofen 30mg/day, Baclofen 60mg, Baclofen 75mg/day, Fleqsuvy, Gablofen, Kemstro, Lioresal, Lyvispah, Ozobax.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.